{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:52:06Z","timestamp":1772117526737,"version":"3.50.1"},"publisher-location":"Chichester, UK","reference-count":72,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd006007.pub3","type":"reference-entry","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T18:06:13Z","timestamp":1346781973000},"source":"Crossref","is-referenced-by-count":2,"title":["Antifibrinolytic amino acids for upper gastrointestinal bleeding in patients with acute or chronic liver disease"],"prefix":"10.1002","author":[{"given":"Arturo J","family":"Mart\u00ed-Carvajal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Sol\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro I","family":"Mart\u00ed-Carvajal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,9,12]]},"reference":[{"key":"10.1002\/14651858.CD006007.pub3-BIB1|cit1","unstructured":"Colle I Wilmer A Le Moine O Debruyne R Delwaide J Dhondt E Upper gastrointestinal tract bleeding management: Belgian guidelines for adults and children Acta Gastro-Enterologica Belgica 2011 45 66"},{"issue":"11","key":"10.1002\/14651858.CD006007.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1111\/j.1572-0241.2000.03299.x","article-title":"Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease","volume":"95","author":"Agarwal","year":"2000","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD006007.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/bmj.328.7438.476","article-title":"Absence of evidence is not evidence of absence","volume":"328","author":"Alderson","year":"2004","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD006007.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-2002-23205","article-title":"Coagulation disorders in liver disease","volume":"22","author":"Amitrano","year":"2002","journal-title":"Seminars in Liver Disease"},{"issue":"4","key":"10.1002\/14651858.CD006007.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD006007.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/ebm.2011.011255","article-title":"Alcoholic liver disease and the potential role of plasminogen activator inhibitor-1 and fibrin metabolism","volume":"237","author":"Beier","year":"2012","journal-title":"Experimental Biology and Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006007.pub3-BIB7|cit7","first-page":"250","article-title":"Primary hyperfibrinolysis in liver disease: a critical review","volume":"9","author":"Bennani-Baiti","year":"2011","journal-title":"Clinical Advances in Hematology & Oncology"},{"issue":"8","key":"10.1002\/14651858.CD006007.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"Brok","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD006007.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ije\/dyn188","article-title":"Apparently conclusive meta-analyses may be inconclusive - Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses","volume":"38","author":"Brok","year":"2009","journal-title":"International Journal of Epidemiology"},{"issue":"7572","key":"10.1002\/14651858.CD006007.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bmj.38987.492014.94","article-title":"How to formulate research recommendations","volume":"333","author":"Brown","year":"2006","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD006007.pub3-BIB11|cit11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2141.2005.05444.x","article-title":"Molecular mechanisms of fibrinolysis","volume":"129","author":"Cesarman-Maus","year":"2005","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD006007.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/bmj.328.7438.475","article-title":"Well informed uncertainties about the effects of treatments","volume":"328","author":"Chalmers","year":"2004","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD006007.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00062752-200211000-00014","article-title":"Transfusion-sparing hemostatic agents","volume":"9","author":"Chiu","year":"2002","journal-title":"Current Opinion in Hematology"},{"key":"10.1002\/14651858.CD006007.pub3-BIB14|cit14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/jhep.2003.50277","article-title":"Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis","volume":"38","author":"Colucci","year":"2003","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD006007.pub3-BIB15|cit15","unstructured":"Copenhagen Trial Unit TSA - Trial Sequential Analysis http:\/\/ctu.dk\/tsa\/"},{"key":"10.1002\/14651858.CD006007.pub3-BIB16|cit16","unstructured":"Deeks JJ Higgins JPT Altman DG Chapter 9: Analysing data and undertaking meta-analyses In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration,"},{"key":"10.1002\/14651858.CD006007.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.thromres.2007.07.008","article-title":"Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency","volume":"121","author":"Ferguson","year":"2008","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD006007.pub3-BIB18|cit18","unstructured":"Gluud C Nikolova D Klingenberg SL Alexakis N Als-Nielsen B Colli A Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2012, Issue 6. Art. No.: LIVER"},{"key":"10.1002\/14651858.CD006007.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2036.2006.02730.x","article-title":"The efficacy and safety of epsilon-aminocaproic acid treatment in patients with cirrhosis and hyperfibrinolysis","volume":"23","author":"Gunawan","year":"2006","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"12","key":"10.1002\/14651858.CD006007.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence - imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD006007.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence - inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD006007.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence - publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD006007.pub3-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence - indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD006007.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jclinepi.2011.06.004","article-title":"GRADE guidelines: 9. Rating up the quality of evidence","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD006007.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence - study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD006007.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD006007.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD006007.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD006007.pub3-BIB29|cit29","unstructured":"Guyatt GH Oxman AD Santesso N Helfand M Vist G Kunz R GRADE guidelines 12. Preparing Summary of Findings tables-binary outcomes Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD006007.pub3-BIB30|cit30","unstructured":"Guyatt G Oxman AD Sultan S Brozek J Glasziou P Alonso-Coello P GRADE guidelines 11-making an overall rating of confidence in effect estimates for a single outcome and for all outcomes Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD006007.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000057299","article-title":"General haemostatic agents-fact or fiction?","volume":"32 Suppl 1","author":"Hedner","year":"2002","journal-title":"Pathophysiology of Haemostasis and Thrombosis"},{"issue":"6681","key":"10.1002\/14651858.CD006007.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1136\/bmj.298.6681.1142","article-title":"Effects of fibrinolytic inhibitors on mortality from upper gastrointestinal haemorrhage","volume":"298","author":"Henry","year":"1989","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"7414","key":"10.1002\/14651858.CD006007.pub3-BIB33|cit33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD006007.pub3-BIB34|cit34","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD006007.pub3-BIB35|cit35","unstructured":"Higgins JPT Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration,"},{"key":"10.1002\/14651858.CD006007.pub3-BIB36|cit36","unstructured":"Higgins JPT Deeks JJ Altman DG Chapter 16: Special topics in statistics In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration,"},{"key":"10.1002\/14651858.CD006007.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1572-0241.2001.03781.x","article-title":"Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit","volume":"96","author":"Hu","year":"2001","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD006007.pub3-BIB38|cit38","volume-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice1997 CFR & ICH Guidelines","volume":"1","year":"1997"},{"key":"10.1002\/14651858.CD006007.pub3-BIB39|cit39","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Better reporting of harms in randomized trials: an extension of the CONSORT statement","volume":"141","author":"Ioannidis","year":"2004","journal-title":"Annals of Internal Medicine"},{"issue":"3-4","key":"10.1002\/14651858.CD006007.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jrsm.19","article-title":"The art of getting it wrong","volume":"1","author":"Ioannidis","year":"2010","journal-title":"Research Synthesis Methods"},{"issue":"9","key":"10.1002\/14651858.CD006007.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2174\/138920111798281036","article-title":"Fibrinolytic factors in liver fibrosis","volume":"12","author":"Kang","year":"2011","journal-title":"Current Pharmaceutical Biotechnology"},{"issue":"6","key":"10.1002\/14651858.CD006007.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1476-4431.2011.00691.x","article-title":"Coagulation in hepatobiliary disease","volume":"21","author":"Kavanagh","year":"2011","journal-title":"Journal of Veterinary Emergency and Critical Care"},{"issue":"11","key":"10.1002\/14651858.CD006007.pub3-BIB43|cit43","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006007.pub3-BIB44|cit44","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJM199807233390407","article-title":"Hemostatic drugs","volume":"339","author":"Mannucci","year":"1998","journal-title":"The New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD006007.pub3-BIB45|cit45","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2165\/11209070-000000000-00000","article-title":"Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis","volume":"72","author":"McCormack","year":"2012","journal-title":"Drugs"},{"issue":"9128","key":"10.1002\/14651858.CD006007.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006007.pub3-BIB47|cit47","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD006007.pub3-BIB48|cit48","first-page":"466","article-title":"The incidence of consumption coagulopathy in liver cirrhosis","volume":"6","author":"Moreno Abad\u00eda","year":"1989","journal-title":"Anales de Medicina Interna"},{"key":"10.1002\/14651858.CD006007.pub3-BIB49|cit49","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.510310214","article-title":"Diurnal changes of fibrinolysis in patients with liver cirrhosis and esophageal varices","volume":"31","author":"Piscaglia","year":"2000","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD006007.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1111\/j.1572-0241.2001.05298.x","article-title":"Liver cirrhosis, ascites, and hyperfibrinolysis","volume":"96","author":"Piscaglia","year":"2001","journal-title":"American Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD006007.pub3-BIB51|cit51","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2478\/v10039-010-0018-3","article-title":"Coagulopathy in liver diseases","volume":"55","author":"Pluta","year":"2010","journal-title":"Advances in Medical Sciences"},{"key":"10.1002\/14651858.CD006007.pub3-BIB52|cit52","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"issue":"4","key":"10.1002\/14651858.CD006007.pub3-BIB53|cit53","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2141.2009.08021.x","article-title":"Haemostasis and thrombosis in liver disease","volume":"148","author":"Roberts","year":"2010","journal-title":"British Journal of Haematology"},{"issue":"5","key":"10.1002\/14651858.CD006007.pub3-BIB54|cit54","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006007.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"1","key":"10.1002\/14651858.CD006007.pub3-BIB56|cit56","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?","volume":"38","author":"Thorlund","year":"2009","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD006007.pub3-BIB57|cit57","first-page":"57","article-title":"Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals","volume":"2","author":"Thorlund","year":"2010","journal-title":"Clinical Epidemiology"},{"key":"10.1002\/14651858.CD006007.pub3-BIB58|cit58","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual for Trial Sequential Analysis (TSA) http:\/\/ctu.dk\/tsa\/files\/tsa_manual.pdf"},{"issue":"2","key":"10.1002\/14651858.CD006007.pub3-BIB59|cit59","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMra1011170","article-title":"The coagulopathy of chronic liver disease","volume":"365","author":"Tripodi","year":"2011","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006007.pub3-BIB60|cit60","first-page":"153","article-title":"Coagulation disorders in cirrhosis","volume":"59","author":"T\u00e9llez-Avila","year":"2007","journal-title":"Revista de Investigaci\u00f3n Cl\u00ednica"},{"issue":"4","key":"10.1002\/14651858.CD006007.pub3-BIB61|cit61","first-page":"433","article-title":"Hemostasis in patients with liver disease","volume":"72","author":"Werf","year":"2009","journal-title":"Acta Gastro-Enterologica Belgica"},{"key":"10.1002\/14651858.CD006007.pub3-BIB62|cit62","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bpg.2007.10.011","article-title":"Epidemiology of acute upper gastrointestinal bleeding","volume":"22","author":"Leerdam","year":"2008","journal-title":"Best Practice & Research. Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD006007.pub3-BIB63|cit63","first-page":"67","article-title":"Coagulation and fibrinolysis in individuals with advanced liver disease","volume":"15","author":"Thiel","year":"2004","journal-title":"The Turkish Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD006007.pub3-BIB64|cit64","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/hep.1840150420","article-title":"Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with advanced cirrhosis","volume":"15","author":"Violi","year":"1992","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD006007.pub3-BIB65|cit65","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/hep.1840170115","article-title":"Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation abnormalities in liver cirrhosis","volume":"17","author":"Violi","year":"1993","journal-title":"Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD006007.pub3-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.jhep.2011.06.008","article-title":"Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?","volume":"55","author":"Violi","year":"2011","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD006007.pub3-BIB67|cit67","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD006007.pub3-BIB68|cit68","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in random-effects model meta-analyses","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"issue":"7644","key":"10.1002\/14651858.CD006007.pub3-BIB69|cit69","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD006007.pub3-BIB70|cit70","unstructured":"Zavala D Mart\u00ed A Pe\u00f1a-Mart\u00ed G Comuni\u00e1n G Sheet to enter data for performing a Cochrane review 2006"},{"issue":"1","key":"10.1002\/14651858.CD006007.pub3-BIB71|cit71","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006007.pub2","article-title":"Antifibrinolytic amino acids for acquired coagulation disorders in patients with liver disease","author":"Marti-Carvajal","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD006007.pub3-BIB72|cit72","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006007.pub2","article-title":"Antifibrinolytic amino acids for acquired coagulation disorders in patients with liver disease","author":"Mart\u00ed-Carvajal","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd006007.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,6,9]],"date-time":"2015-06-09T00:00:00Z","timestamp":1433808000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD006007.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:53:43Z","timestamp":1628531623000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006007.pub3"}},"subtitle":[],"editor":[{"given":"Arturo J","family":"Mart\u00ed-Carvajal","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,9,12]]},"references-count":72,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006007.pub3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717958461.793463430","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2012,9,12]]}}}